Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Northwest Biotherapeutics Inc
OTC:NWBO
Northwest Biotherapeutics Inc
OTC:NWBO
Price:
0.148
USD
0.75%
Market Closed
Market Cap:
$243.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Northwest Biotherapeutics Inc
OTC:NWBO
|
US |
|
P
|
Public Power Corporation SA
F:PU8
|
GR |
|
U
|
Ultralife Corp
SWB:ULB
|
US |
|
Danske Andelskassers Bank A/S
CSE:DAB
|
DK |
|
K
|
KGL Resources Ltd
F:KN6
|
AU |
|
A
|
Altri SGPS SA
ELI:ALTR
|
PT |
|
E
|
Elis SA
OTC:ELSSF
|
FR |
|
C
|
Cuscal Ltd
ASX:CCL
|
AU |
Wall St Price Targets
NWBO Price Forecast
+589% Upside
from
$0.148
today
Northwest Biotherapeutics Inc (NWBO)’s 12-month stock price forecast through October 2027 has a consensus target of $1.02, implying 589% upside.
NWBO Analyst Rating
No ratings yet
No ratings yet
Northwest Biotherapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NWBO's stock price target?
Price Target
1.02
USD
1.02
USD
According to Wall Street analysts, the average 1-year price target for NWBO is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.
What is the Revenue forecast for Northwest Biotherapeutics Inc?
Projected CAGR
445%
445%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 2 years is 445%.